Taro Pharmaceutical (TARO)

Add to Watchlists
Create an Alert
116.06 +2.04  +1.79% NYSE Jun 23, 20:00 Delayed 2m USD

Taro Pharmaceutical Shareholders Equity (Quarterly):

2.067B for March 31, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Taro Pharmaceutical Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Taro Pharmaceutical Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 1987. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 2.067B
Dec. 31, 2016 1.996B
Sept. 30, 2016 1.913B
June 30, 2016 1.913B
March 31, 2016 1.931B
Dec. 31, 2015 1.770B
Sept. 30, 2015 1.610B
June 30, 2015 1.524B
March 31, 2015 1.412B
Dec. 31, 2014 1.317B
Sept. 30, 2014 1.197B
June 30, 2014 1.081B
March 31, 2014 1.016B
Dec. 31, 2013 944.70M
Sept. 30, 2013 1.037B
June 30, 2013 931.31M
March 31, 2013 886.35M
Dec. 31, 2012 843.39M
Sept. 30, 2012 756.84M
June 30, 2012 680.68M
March 31, 2012 619.01M
Dec. 31, 2011 567.26M
Sept. 30, 2011 499.11M
June 30, 2011 455.41M
March 31, 2011 417.07M
   
Dec. 31, 2010 381.31M
Sept. 30, 2010 297.51M
June 30, 2010 256.10M
Dec. 31, 2009 292.97M
Sept. 30, 2009 228.69M
June 30, 2009 211.07M
March 31, 2009 198.59M
Dec. 31, 2008 164.22M
Sept. 30, 2008 206.04M
Dec. 31, 2005 128.07M
Sept. 30, 2005 384.14M
June 30, 2005 377.74M
March 31, 2005 374.11M
Dec. 31, 2004 368.12M
Sept. 30, 2004 357.33M
June 30, 2004 349.85M
March 31, 2004 356.92M
Dec. 31, 2003 347.40M
Sept. 30, 2003 320.33M
June 30, 2003 304.92M
March 31, 2003 286.55M
Dec. 31, 2002 269.14M
Sept. 30, 2002 249.91M
June 30, 2002 239.52M
March 31, 2002 228.31M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Shareholders' Equity

Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More

Advertisement

TARO Shareholders Equity (Quarterly) Benchmarks

Companies
Dr Reddy's Laboratories 1.913B
Teva Pharmaceutical Indus 34.02B
Impax Laboratories 540.88M

TARO Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 680.68M Jun 2012
Maximum 2.067B Mar 2017
Average 1.341B

TARO Shareholders Equity (Quarterly) Excel Add-In Codes

  • Metric Code: shareholders_equity
  • Latest data point: =YCP("TARO", "shareholders_equity")
  • Last 5 data points: =YCS("TARO", "shareholders_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.